The application of rotational atherectomy in PCI for patients with complex coronary artery calcified lesions

旋切术在经皮冠状动脉介入治疗(PCI)中对复杂冠状动脉钙化病变患者的应用

阅读:2

Abstract

OBJECTIVE: To evaluate the safety and efficacy of rotational atherectomy (RA) in the treatment of complex coronary calcified lesions and to identify factors associated with patient prognosis. METHODS: A retrospective study was conducted on 200 patients who underwent RA at Hunan Provincial People's Hospital between January 2022 and March 2024. Baseline demographics, angiographic, procedural, and laboratory variables were collected. Major adverse cardiovascular events (MACE) after discharge were recorded through scheduled clinic visits and telephone follow-up (median, 12 months). All patients received standardized RA, intracoronary imaging guidance, and 12-month dual antiplatelet therapy. Pre- and post-procedural parameters were compared using paired tests, and multivariable logistic regression was performed to identify independent predictors of adverse outcomes. RESULTS: RA significantly increased the minimum lumen area (2.31 mm(2) vs. 5.80 mm(2), P<0.001) and minimum lumen diameter (1.61 mm vs. 2.50 mm, P<0.001). Among the 181 patients completing follow-up, 43 (23.8%) developed heart failure, and 19 (10.5%) died. Multivariate analysis identified hypertension (OR=3.201, P=0.005) and diabetes mellitus (DM, OR=1.915, P=0.038) as independent risk factors for poor prognosis. In patients with both hypertension and DM, older age (OR=1.069, P=0.046), left main coronary artery lesion (OR=4.270, P=0.013), and maximum burr diameter (OR=292.231, P=0.006) were strongly associated with adverse outcomes. CONCLUSION: RA effectively improves luminal dimensions in complex coronary calcified lesions. Concomitant hypertension and DM are independent risk factors for poor prognosis after RA. Among patients with both conditions, advanced age, left main coronary artery lesion, and larger maximum burr diameter may predict worse clinical outcomes.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。